Outcome of carfilzomib/pomalidomide-based regimens after daratumumab-based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis

Richard LeBlanc, Hira Mian, Donna Reece, Jiandong Su, Esther Masih-Khan, Michael Chu, Victor Jimenez-Zepeda, Michael Sebag, Kevin Song, Martha Louzada, Rami Kotb, Alissa Visram, Darrell White, Julie Stakiw, Antony Reiman, Muhammad Aslam, Debra Bergstrom, Rayan Kaedbey, Engin Gul, Christopher Venner

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)815-823
Number of pages9
JournalEuropean Journal of Haematology
Volume111
Issue number5
DOIs
Publication statusPublished - Nov 2023

ASJC Scopus Subject Areas

  • Hematology

Keywords

  • carfilzomib
  • multiple myeloma
  • pomalidomide
  • post-daratumumab
  • real-world data

Fingerprint

Dive into the research topics of 'Outcome of carfilzomib/pomalidomide-based regimens after daratumumab-based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis'. Together they form a unique fingerprint.

Cite this